Immunocore is a privately owned British clinical-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs to treat cancer, infectious diseases and autoimmune diseases using soluble T-cell receptor technology.

Biotechnology

Immunocore

Immunocore's headquarters in Milton, United Kingdom

This department focuses on the development and optimization of drug formulation processes and stability assessments.

Formulation Development

This department conducts scientific research and development to advance knowledge and innovation in various fields.

Research and Development

This department oversees the planning and implementation of clinical trials and regulatory strategies to ensure the development and approval of new therapies.

Clinical Development

This department focuses on managing and coordinating oncology accounts and clients.

Oncology Management

This department focuses on advancing research and development in protein engineering, structural biology, and related fields to drive scientific innovations.

Protein Science Research

This department oversees the planning, execution, and management of projects to ensure successful delivery and alignment with organizational goals.

Program Management

The Leadership Team at Immunocore is responsible for setting the strategic vision and direction of the company, driving innovation in T-cell receptor technology, and overseeing the progression of drug development from research through clinical trials. This team includes key executives who manage operations across various domains, including chemistry, manufacturing, regulatory affairs, finance, and business development, ensuring alignment with the company’s goals to advance therapies for cancer, infectious, and autoimmune diseases.

People (4)

Jobs (0)

Other teams

Research and Development

Clinical Development

Oncology Management

Protein Science Research

Program Management

Leadership Team